Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

13 results
Display

Radiation segmentectomy for gastric leiomyosarcoma hepatic metastasis

Roh S

  • Korean J Clin Oncol.
  • 2018 Dec;14(2):142-145.
  • doi: 10.14216/kjco.18024
Metastases to the liver can be found in various malignancies, most commonly originating from the colon, rectum, pancreas, stomach, esophagus, breast, lung, and melanoma. Surgical resection of liver metastasis is...
Use of positron emission tomography-computed tomography to predict axillary metastasis in patients with triple-negative breast cancer

Youm JH, Chung Y, Yang YJ, Han SA, Song JY

  • Korean J Clin Oncol.
  • 2018 Dec;14(2):135-141.
  • doi: 10.14216/kjco.18023
PURPOSE: Axillary lymph node dissection (ALND) and sentinel lymph node biopsy (SLNB) are important for staging of patients with node-positive breast cancer. However, these can be avoided in select micrometastatic...
Tissue factor expression is associated with recurrence in patients with non-metastatic colorectal cancer

Jung HJ, Kim HJ, Kaneko K, Kazama Y, Kawai K, Ishihara S, Choi GS

  • Korean J Clin Oncol.
  • 2018 Dec;14(2):128-134.
  • doi: 10.14216/kjco.18022
PURPOSE: Previous studies have addressed the role of the hypercoagulable state in the pathogenesis of cancer progression and metastasis. In this study, we investigated the association between coagulation factors, including...
The impact of lymph node count on survival in gastric cancer

Ahn HR, Han SW, Yang DH, Kim CY

  • Korean J Clin Oncol.
  • 2018 Dec;14(2):120-127.
  • doi: 10.14216/kjco.18021
PURPOSE: The purpose of this study was to determine the immunologic role of lymph node (LN) and stage migration by assessing LN count and metastatic LN count. METHODS: A total of...
The efficacy of chemotherapy in the patients with stage II colon cancer associated with number of high-risk factors

Kim MJ, Baek SH, Ko S

  • Korean J Clin Oncol.
  • 2018 Dec;14(2):116-119.
  • doi: 10.14216/kjco.18020
PURPOSE: This study assessed the effect of chemotherapy over stage II colon cancer in terms of presence of high-risk factors. METHODS: Data were retrospectively reviewed for 364 patients with stage II...
Nine months versus 12 months of adjuvant trastuzumab for patients with HER2-positive breast cancer

El-Enbaby , El Moneim , El atti Khedr GA, Elwany YM

  • Korean J Clin Oncol.
  • 2018 Dec;14(2):108-115.
  • doi: 10.14216/kjco.18019
PURPOSE: This study aimed to compare the results of treatment with adjuvant trastuzumab for 9 months versus 12 months in human epidermal growth factor 2 (HER2)-positive breast cancer patients. The...
Long-term cardiac composite risk following adjuvant treatment in breast cancer patients

Choi HB, Yun S, Cho SW, Lee MH, Lee J, Park S

  • Korean J Clin Oncol.
  • 2018 Dec;14(2):102-107.
  • doi: 10.14216/kjco.18018
PURPOSE: Cardiotoxicity is a serious late complication of breast cancer treatment. Individual treatment risk of specific drugs has been investigated. However, studies on the evaluation of the composite risk of...
Experiences of thoracic esophagectomy with laparoscopic gastric pull up in thoracic esophageal cancer patient in single center

Jun JW, Kim W, Park JM

  • Korean J Clin Oncol.
  • 2018 Dec;14(2):95-101.
  • doi: 10.14216/kjco.18017
PURPOSE: The standard treatment of esophageal cancer is the Ivor-Lewis operation, which consists of an abdominal phase involving gastric tube formation, and a chest phase involving esophagectomy and anastomosis. We...
Clinicopathologic correlation with MUC expression in advanced gastric cancer

Kim K, Choi KW, Lee WY

  • Korean J Clin Oncol.
  • 2018 Dec;14(2):89-94.
  • doi: 10.14216/kjco.18016
PURPOSE: To investigate the relationship between MUC expression and clinicopathologic factors in advanced gastric cancer. METHODS: A total of 237 tumor specimens were assessed for MUC expression by immunohistochemistry. The clinicopathologic...
Clinicopathologic characteristics and survival rate in patients with synchronous or metachronous double primary colorectal and gastric cancer

Park JH, Baek JH, Yang JY, Lee WS, Lee WK

  • Korean J Clin Oncol.
  • 2018 Dec;14(2):83-88.
  • doi: 10.14216/kjco.18015
PURPOSE: Double primary colorectal cancer (CRC) and gastric cancer (GC) represent the most common multiple primary malignant tumors (MPMT) in Korea. The recognition and screening of hidden malignancies other than...
Clinical relevance of Lgr5 expression in colorectal cancer patients

Kim YJ, Kang DH, Song GJ, Ahn TS, Son MW, Lee MS, Baek MJ

  • Korean J Clin Oncol.
  • 2018 Dec;14(2):76-82.
  • doi: 10.14216/kjco.18014
PURPOSE: Lgr5 is a well-known stem cell marker in colorectal cancer (CRC). This retrospective study evaluated the expressions of Lgr5 in CRC specimens, and examined whether these expressions were associated...
Changing trends in clinico-pathologic characteristics and treatment outcomes in patients with gastric cancer: A single-center, public hospital, retrospective study

Gwak MS, Park JM

  • Korean J Clin Oncol.
  • 2018 Dec;14(2):69-75.
  • doi: 10.14216/kjco.18013
PURPOSE: We analyzed our 10-year experience in a single-center, public hospital and thereby evaluated the changing trends of clinico-pathologic and surgical characteristics as well as treatment outcomes in patients with...
Adjuvant chemotherapy in patients with stage II colon cancer

Kim HJ

  • Korean J Clin Oncol.
  • 2018 Dec;14(2):67-68.
  • doi: 10.14216/kjco.18012
No abstract available.

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr